Lisdexamfetamine Dimesylate Augmentation for Adults With Major Depressive Disorder and Inadequate Response to Antidepressant Monotherapy: Results From 2 Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies